Genetically Proxied Lipid-Lowering Drug Target Perturbation and Ischemic Stroke Risk in European and African Ancestry Individuals: Mendelian Randomization Study

Affiliations

• ¹ The African Computational Genomics Research Group, Medical Research Council/Uganda Virus Research Institute, and London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM), Entebbe, Uganda (O.S., G.K., S.F.).
• ² Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, United Kingdom (O.S.).
• ³ Molecular Bio-Computation and Drug Design Laboratory, School of Health Sciences, University of KwaZulu-Natal, Westville Campus, Durban, South Africa (O.S., T.M.).
• ⁴ Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, United Kingdom (O.S, D.G.).
• ⁵ Osun State University, Osogbo, Nigeria (C.A.).
• ⁶ MRC/Wits Developmental Pathways for Health Research Unit, Department of Pediatrics, Faculty of Health Sciences (T.C.), University of the Witwatersrand, Johannesburg, South Africa.
• ⁷ Sydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences (T.C.), University of the Witwatersrand, Johannesburg, South Africa.
• ⁸ Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA (T.C.).
• ⁹ Harvard Medical School, Boston, MA (T.C.).
• ¹⁰ Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine London, United Kingdom (S.F.).
• ¹¹ Precision Healthcare University Research Institute Queen Mary University of London, United Kingdom (S.F.).